Hybridize Therapeutics Revenue

Biotechnology Research • Leiden, South Holland, Netherlands • 1-10 Employees

Hybridize Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Hybridize Therapeutics

Anton Jan Van Zonneveld

Scientific co-Founder Hybridize Therapeutics

Company overview

Headquarters	Leiden, South Holland, Netherlands
Phone number	+3120072019
Website	hybridizetherapeutics.com
NAICS	541714
Founded	2019
Employees	1-10
Socials

About Hybridize Therapeutics

Hybridize's mission is to help patients overcome untreated kidney diseases. We do this by developing RNA-based therapies. Currently, we are nearing Phase 1 clinical trials (together with our partner AiCuris Anti-Infectives) for our therapy against BK-virus.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Funding Data

Hybridize Therapeutics has never raised funding before.

Hybridize Therapeutics Tech Stack

Discover the technologies and tools that power Hybridize Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

Autoptimize

Performance

GoDaddy

Hosting

Contact Form 7

Form builders

PHP

Programming languages

Open Graph

Miscellaneous

Complianz

A/B Testing

WordPress

Blogs

Google Analytics

Analytics

MySQL

Databases

LazySizes

JavaScript libraries

Frequently asked questions

Hybridize Therapeutics is located in Leiden, South Holland, NL.

You can reach Hybridize Therapeutics at +3120072019.

Hybridize Therapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Hybridize Therapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Hybridize Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Hybridize Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Hybridize Therapeutics

Anton Jan Van Zonneveld

Scientific co-Founder Hybridize Therapeutics

4.8

40,000 users